Back

Body composition based on bioelectrical impedance analysis in patients after decompensated heart failure with sacubitril/valsartan therapy within 6 month of treatment

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Pharmacotherapy HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Svyatoslav Galochkin

Peoples Friendship University of Russia (RUDN University), Moscow (Russian Federation)

738 More presentations in this session

Presentation thumbnail
Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Abstract Slides
Presentation thumbnail
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Doctor D. Moysidis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
Doctor A. Safiullina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?
Doctor H. Santos (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Body composition and hydric state analysis in heart failure patients with reduced and preserved ejection fraction.
20 May 2023
thumbnail
Congress Presentation
Sacubitril/valsartan treatment: effect on left ventricular remodelling and fibrosis assessed by novel heart failure biomarkers
26 August 2022
thumbnail
Congress Presentation
Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial
20 May 2023
thumbnail
Congress Presentation
Appendicular skeletal muscle mass increases during cardiac rehabilitation program following discharge in hospitalized patients with cardiovascular diseases
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources